Hyperlipidaemia type 3 (Q88107): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed an Item
‎Changed an Item
 
(4 intermediate revisions by the same user not shown)
Property / CURIE
 
CID11:ID_1400598695
Property / CURIE: CID11:ID_1400598695 / rank
 
Normal rank
Property / Canary Token
 
dki-india-ID_1400598695
Property / Canary Token: dki-india-ID_1400598695 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank

Latest revision as of 14:12, 15 August 2026

This involves abnormally elevated levels of any or all lipids and/or lipoproteins in the blood. This form is due to high chylomicrons and IDL (intermediate density lipoprotein). Also known as broad beta disease or dysbetalipoproteinaemia, the most common cause for this form is the presence of ApoE E2/E2 genotype. It is due to cholesterol-rich VLDL (?-VLDL).
Language Label Description Also known as
default for all languages
ID_1400598695
    English
    Hyperlipidaemia type 3
    This involves abnormally elevated levels of any or all lipids and/or lipoproteins in the blood. This form is due to high chylomicrons and IDL (intermediate density lipoprotein). Also known as broad beta disease or dysbetalipoproteinaemia, the most common cause for this form is the presence of ApoE E2/E2 genotype. It is due to cholesterol-rich VLDL (?-VLDL).

      Statements

      CID11:ID_1400598695
      0 references
      dki-india-ID_1400598695
      0 references
      Concluído
      0 references
      13 August 2026
      0 references